The World Health Organization has initiated a clinical trial to test an antiviral drug for preventing infection from the Bundibugyo strain of Ebola in the Democratic Republic of Congo.
WHO begins trial of antiviral to prevent Bundibugyo Ebola strain


The World Health Organization has initiated a clinical trial to test an antiviral drug for preventing infection from the Bundibugyo strain of Ebola in the Democratic Republic of Congo.